Home > Insider Trading > Filing (0000950170-25-083321)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1582313	Xenon Pharmaceuticals Inc.	XENE	Pharmaceutical Preparations (2834)	980661854

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643085	Steven Gannon	3650 Gilmore Way Burnaby A1 V5G 4W8		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2025-06-05	3	$30.48	7,141	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Share Option (Right to Buy)	Acquisiton	2025-06-05	17,012	$0.00	17,012	$30.73
Common Shares	Restricted Share Units	Acquisiton	2025-06-05	2,645	$0.00	2,645	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,012		2035-06-04	No	4	A	Direct
2,645			No	4	A	Direct

Footnotes

Shares automatically sold in payment of transfer fee for transfer of shares to an alternate brokerage account.
Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders.
Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders.